• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Elbit Systems Shares Are Trading Lower By Over 10%; Here Are 24 Stocks Moving Premarket

    11/29/22 7:28:25 AM ET
    $ATHX
    $BILI
    $BZ
    $CFRX
    Biotechnology: Pharmaceutical Preparations
    Health Care
    EDP Services
    Technology
    Get the next $ATHX alert in real time by email

    Gainers

    • NanoVibronix, Inc. (NASDAQ:NAOV) shares rose 26.3% to $0.7994 in pre-market trading after the company received FDA 510K premarket clearance for PainShield Plus, its dual-actuator ultrasound pain therapy device.
    • Cosmos Holdings Inc. (NASDAQ:COSM) rose 20.3% to $0.6983 in pre-market trading after jumping 35% on Monday.
    • Kala Pharmaceuticals, Inc (NASDAQ:KALA) shares rose 18.5% to $6.73 in pre-market trading. Kala Pharmaceuticals reported submission of investigational New Drug Application for KPI-012 for the treatment of persistent corneal epithelial defect. The company also announced private placement financing for gross proceeds of up to $31 million.
    • Lizhi Inc. (NASDAQ:LIZI) rose 16.6% to $0.6883 in pre-market trading. The company recently swung to a profit in the third quarter.
    • GDS Holdings Limited (NASDAQ:GDS) shares rose 12.7% to $13.20 in pre-market trading. The company recently posted upbeat quarterly sales.
    • Zhihu Inc. (NYSE:ZH) rose 11.4% to $1.01 in pre-market trading after declining over 9% on Monday.
    • Bilibili Inc. (NASDAQ:BILI) rose 10.3% to $13.88 in pre-market trading.
    • Eqonex Limited (NASDAQ:EQOS) rose 10.1% to $0.1550 in pre-market trading.
    • ContraFect Corporation (NASDAQ:CFRX) rose 10% to $0.1595 in pre-market trading. ContraFect announced ANSM approval of clinical trial application for Exebacase in prosthetic joint infections.
    • ThermoGenesis Holdings, Inc. (NASDAQ:THMO) rose 8.2% to $0.1280 in pre-market trading. ThermoGenesis recently posted a Q3 loss of $0.10 per share.
    • Yatsen Holding Limited (NYSE:YSG) rose 7.8% to $1.25 in pre-market trading. The company recently posted upbeat Q3 results.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) rose 7.5% to $0.1075 in pre-market trading.
    • JD.com, Inc. (NASDAQ:JD) gained 7.4% to $53.59 in pre-market trading. JD.com is looking to lower pay by up to 20% for senior executives, according to Financial Times.
    • Kanzhun Limited (NASDAQ:BZ) rose 7.3% to $16.20 in pre-market trading after gaining over 5% on Monday.
    • JOYY Inc. (NASDAQ:YY) rose 5.7% to $29.10 in pre-market trading following upbeat quarterly earnings.


    Don’t forget to check out our premarket coverage here .


    Losers

    • CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) fell 19% to $4.06 in pre-market trading. CNS Pharmaceuticals announced a 1-for-30 reverse stock split.
    • Alaunos Therapeutics, Inc. (NASDAQ:TCRT) shares fell 15.2% to $0.7399 in pre-market trading after the company reported a proposed public offering of common stock.
    • MICT, Inc. (NASDAQ:MICT) fell 14.2% to $0.9699 in pre-market trading after dropping 13% on Monday.
    • Elbit Systems Ltd. (NASDAQ:ESLT) fell 10.6% to $166.99 in pre-market trading after the company reported a drop in profit for the third quarter.
    • Huize Holding Limited (NASDAQ:HUIZ) shares fell 8.7% to $1.05 in pre-market trading after jumping over 16% on Monday.
    • FOXO Technologies Inc. (NASDAQ:FOXO) fell 8.1% to $0.51 in pre-market trading after dropping around 10% on Monday.
    • Athersys, Inc. (NASDAQ:ATHX) shares fell 7.2% to $0.5512 in pre-market trading.
    • iCAD, Inc. (NASDAQ:ICAD) shares fell 6.8% to $1.77 in pre-market trading. iCAD shares gained over 5% on Monday after the company announced a strategic development and commercialization agreement with Google Health.
    • Credit Suisse Group AG (NYSE:CS) fell 4.2% to $3.23 in pre-market trading. The company last week said it expects to post a loss for the quarter.
    Get the next $ATHX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ATHX
    $BILI
    $BZ
    $CFRX

    CompanyDatePrice TargetRatingAnalyst
    JD.com Inc.
    $JD
    4/17/2026Neutral → Buy
    Arete
    JD.com Inc.
    $JD
    4/14/2026Neutral → Outperform
    Macquarie
    Bilibili Inc.
    $BILI
    4/13/2026$31.00Equal-Weight → Overweight
    Morgan Stanley
    Bilibili Inc.
    $BILI
    3/27/2026$27.00Neutral → Buy
    Citigroup
    Bilibili Inc.
    $BILI
    3/17/2026$35.00Neutral → Overweight
    Analyst
    Elbit Systems Ltd.
    $ESLT
    12/11/2025Equal-Weight
    Morgan Stanley
    JD.com Inc.
    $JD
    12/9/2025$32.00Buy → Neutral
    Arete
    JD.com Inc.
    $JD
    11/10/2025$28.00Equal-Weight → Underweight
    Morgan Stanley
    More analyst ratings

    $ATHX
    $BILI
    $BZ
    $CFRX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $45,000 worth of shares (90,325 units at $0.50), increasing direct ownership by 1% to 8,182,120 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    1/26/26 11:48:12 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ATHX
    $BILI
    $BZ
    $CFRX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Wang Han

    4 - Zhihu Inc. (0001835724) (Issuer)

    4/21/26 8:53:47 AM ET
    $ZH
    Real Estate

    SEC Form 4 filed by Ma Cunjun

    4 - Huize Holding Ltd (0001778982) (Issuer)

    4/20/26 6:09:59 AM ET
    $HUIZ
    Specialty Insurers
    Finance

    SEC Form 3 filed by new insider Cohen Boaz

    3 - ELBIT SYSTEMS LTD (0001027664) (Issuer)

    4/16/26 12:16:02 PM ET
    $ESLT
    Military/Government/Technical
    Industrials

    $ATHX
    $BILI
    $BZ
    $CFRX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    JD.com upgraded by Arete

    Arete upgraded JD.com from Neutral to Buy

    4/17/26 9:26:04 AM ET
    $JD
    Other Specialty Stores
    Consumer Discretionary

    JD.com upgraded by Macquarie

    Macquarie upgraded JD.com from Neutral to Outperform

    4/14/26 2:47:39 PM ET
    $JD
    Other Specialty Stores
    Consumer Discretionary

    Bilibili upgraded by Morgan Stanley with a new price target

    Morgan Stanley upgraded Bilibili from Equal-Weight to Overweight and set a new price target of $31.00

    4/13/26 8:37:56 AM ET
    $BILI
    EDP Services
    Technology

    $ATHX
    $BILI
    $BZ
    $CFRX
    SEC Filings

    View All

    SEC Form 6-K filed by KANZHUN LIMITED

    6-K - Kanzhun Ltd (0001842827) (Filer)

    4/24/26 8:53:31 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    SEC Form 20-F filed by Huize Holding Limited

    20-F - Huize Holding Ltd (0001778982) (Filer)

    4/24/26 8:02:08 AM ET
    $HUIZ
    Specialty Insurers
    Finance

    SEC Form 6-K filed by KANZHUN LIMITED

    6-K - Kanzhun Ltd (0001842827) (Filer)

    4/23/26 7:43:08 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    $ATHX
    $BILI
    $BZ
    $CFRX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Huize Holding Limited Files 2025 Annual Report on Form 20-F

    SHENZHEN, China, April 24, 2026 (GLOBE NEWSWIRE) -- Huize Holding Limited, ("Huize," the "Company" or "we") (NASDAQ:HUIZ), a leading insurance technology platform connecting consumers, insurance carriers, and distribution partners digitally through data-driven and AI-powered solutions in Asia, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the U.S. Securities and Exchange Commission (the "SEC") on April 24, 2026. The annual report can be accessed on the SEC's website at www.sec.gov and on the Company's investor relations website at http://ir.huize.com. The Company will provide hardcopies of the annual report, free of charg

    4/24/26 8:20:09 AM ET
    $HUIZ
    Specialty Insurers
    Finance

    BOSS Zhipin's Ongoing Share Repurchases Cross the RMB1 Billion Mark in 2026

    BEIJING, April 24, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing over RMB27.3 million to repurchase 597,224 ordinary shares on April 23. With this latest repurchase, the Company has deployed over RMB1 billion toward share repurchases year-to-date in 2026. This effort underscores the Company's ongoing commitment to delivering value to shareholders. CONTACT: PIACENTE FINANCIAL COMMUNICATIONS [email protected]

    4/24/26 6:30:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    BOSS Zhipin's Ongoing Share Repurchases Exceed RMB985 Million in 2026

    BEIJING, April 23, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing over RMB27.2 million to repurchase 580,426 ordinary shares on April 22. Year-to-date in 2026, the Company has deployed over RMB985 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns. CONTACT: PIACENTE FINANCIAL COMMUNICATIONS [email protected]

    4/23/26 6:30:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    $ATHX
    $BILI
    $BZ
    $CFRX
    Financials

    Live finance-specific insights

    View All

    The Three-Layer Counter-UAS Stack: VisionWave Assembles RF + Computer Vision + AI Video Analytics Architecture with Foresight Investment

    Issued on behalf of VisionWave Holdings, Inc.VisionWave Holdings (NASDAQ:VWAV) signs a non-binding term sheet to acquire up to 51% of Foresight Autonomous Holdings (NASDAQ:FRSX), adding camera-based stereo vision and thermal perception to its existing RF sensing core and the xClibre™ AI video intelligence platform — building toward a three-layer counter-UAS architecture targeting its Argus™ platform and intended to reduce false-positive engagement rates.Companies mentioned in this article:VisionWave Holdings, Inc. (NASDAQ:VWAV), Foresight Autonomous Holdings Ltd. (NASDAQ:FRSX), L3Harris Technologies, Inc. (NYSE:LHX), Teledyne Technologies Incorporated (NYSE:TDY), Elbit Systems Ltd. (NASDAQ:E

    4/21/26 9:59:00 AM ET
    $ESLT
    $FRSX
    $LHX
    Military/Government/Technical
    Industrials
    Computer Software: Prepackaged Software
    Technology

    BOSS Zhipin Continues Share Repurchases, with Total Repurchases Amounting to Nearly RMB700 Million in 2026

    BEIJING, April 07, 2026 (GLOBE NEWSWIRE) -- KANZHUN LIMITED ("BOSS Zhipin" or the "Company") (NASDAQ:BZ, HK: 2076)) today announced the continued execution of its share repurchase program, utilizing around RMB55.0 million to repurchase 1,180,162 ordinary shares on April 2 and April 6. Year-to-date in 2026, the Company has deployed nearly RMB700 million toward share repurchases. This move underscores the Company's ongoing commitment to shareholder returns. The Company also announced on March 18, 2026 that for each of the next three years starting from 2026, it will allocate no less than 50% of the Company's adjusted net income (a non-GAAP financial measure) from the preceding fiscal year f

    4/7/26 6:30:00 AM ET
    $BZ
    Computer Software: Programming Data Processing
    Technology

    Huize Holding Limited Reports Unaudited Financial Results for the Second Half and Full Year 2025

    SHENZHEN, China, March 27, 2026 (GLOBE NEWSWIRE) -- Huize Holding Limited, ("Huize", the "Company" or "we") (NASDAQ:HUIZ), a leading insurance technology platform connecting consumers, insurance carriers, and distribution partners digitally through data-driven and AI-powered solutions in Asia, today announced its unaudited financial results for the second half and full year ended December 31, 2025. Full Year 2025 Financial and Operational Highlights Record-breaking insurance premiums: Both first year premiums ("FYP") and gross written premiums ("GWP") reached record highs of RMB4,630.8 million and RMB7,427.1 million in 2025, representing robust increases of 35.4% and 20.6% year-over-yea

    3/27/26 5:00:00 AM ET
    $HUIZ
    Specialty Insurers
    Finance

    $ATHX
    $BILI
    $BZ
    $CFRX
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

    Continues to deliver record revenue and improving operating metricsSignificant expansion in the United States underway, with NOOR and other Sky Premium Life products expected to drive strong profitability supported by gross margins of approximately 75%NOOR Collagen alone is projected to generate more than $12 million in annualized revenue Strong growth expected ahead, driven by organic progress and M&A pipeline including a recent LOI to acquire an $11.5 million pharmacy distribution network Holds valuable non-core strategic real estate and digital assets with an estimated fair market value exceeding $18 million, providing meaningful balance sheet flexibilityEvaluating potential monetization

    3/19/26 12:45:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    ENvue Medical Appoints Industry Veteran Marc Waldman as Vice President, Commercial

    TYLER, Texas, Jan. 21, 2026 (GLOBE NEWSWIRE) -- ENvue Medical, Inc. (NASDAQ:FEED) (NASDAQ:NAOV) ("ENvue," "ENvue Medical" or the "Company"), a medical technology company specializing in the advancement of intelligent, non-invasive solutions for enteral care across clinical and home care settings, today announced the appointment of Marc Waldman as Vice President, Commercial. In this role, Mr. Waldman will lead ENvue's U.S. commercialization strategy, with a focus on expanding its existing presence in 38 hospitals and accelerating revenue across the Company's enteral platform. "Marc is a highly accomplished sales leader with extensive GPO and IDN expertise and long-standing relationships th

    1/21/26 8:30:00 AM ET
    $FEED
    $NAOV
    Industrial Specialties
    Health Care

    $ATHX
    $BILI
    $BZ
    $CFRX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by JOYY Inc.

    SC 13G/A - JOYY Inc. (0001530238) (Subject)

    11/14/24 7:58:46 PM ET
    $YY
    EDP Services
    Technology

    Amendment: SEC Form SC 13G/A filed by NanoVibronix Inc.

    SC 13G/A - NanoVibronix, Inc. (0001326706) (Subject)

    11/14/24 5:17:34 PM ET
    $NAOV
    Industrial Specialties
    Health Care

    Amendment: SEC Form SC 13G/A filed by Cosmos Health Inc.

    SC 13G/A - Cosmos Health Inc. (0001474167) (Subject)

    11/14/24 4:50:24 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care